GLGT - Global General Technologies Inc.

[smartinvest22]

This is what I excerpted off the Friday tips:

GLGT
The company’s new AB (Wuhan) Biotech subsidiary should soon be making
an exciting announcement about its involvement in a venture focused on
diagnosing, preventing and treating rabies.

Also it was reported that GLGT boasted revenues of $1.8 million in 2010!

[smartinvest22]

According to the PR as of May 10 they're on track of making some big announcements:

Global General Technologies Inc. (GLGT) Reveals 2010 Revenues and
Profits
HENDERSON, NEVADA–(Marketwire – April 25, 2011) – Global General
Technologies Inc. (PINK SHEETS:GLGT) (Welcome To Global General Technologoes) and its
main subsidiary, AB (Wuhan) Biotech Co. Ltd., have revealed the
company’s revenues and profits for 2010.
AB (Wuhan) Biotech boasted revenues of $1,840,354.92 U.S. and profits
of $360,776.48 U.S. in 2010. GLGT recently acquired AB (Wuhan)
Biotech, a Wuhan, China-based biotech company that’s committed to
developing, commercializing and popularizing advanced In Vitro
Diagnostic (IVD) kits/devices.
GLGT and AB (Wuhan) Biotech release this information to show the true
value brought to GLGT by the merger with its new subsidiary. GLGT
management is pleased with these financial results and feels that,
following a long period of silence, company followers deserve to see
as much information as possible.

[smartinvest22]

Something I came up with a while ago while doing my industry research, a good read:


According to our latest report entitled “Global In Vitro Diagnostic
Market Analysis”, the IVD market worldwide has been witnessing
impressive growth rate patterns for the last few years. The market is
primarily growing on the back of drivers, such as technological
advancements, increasing prevalence of diseases, and rising healthcare
spending. The global IVD market reached to the mark of US$ 44 Billion
in 2010 and is likely to reach around US$ 52 Billion by 2013.
Our report has found that China is likely to become one of the fastest
growing regions for diagnostic products. Increasing number of private
laboratories and extended reference laboratories are boosting the
demand for tests of all kinds, thus driving the growth of the Chinese
IVD market. The IVD market in China was estimated at around US$ 2.5
Billion in 2010 and is expected to be of worth around US$ 5 Billion by
2013.
According to our report “Global In Vitro Diagnostic Market Analysis”
the point of care testing is the top segment in global IVD market
followed by immunochemistry & clinical chemistry. Other segments have
also been witnessing significant developments and are likely to expand
their share in the overall market. The report also identifies some of
the key disease areas, in which, industry players are focusing and
investments are being poured. Development from the perspectives of IVD
in diseases, such as diabetes, cancer, HIV, influenza, tuberculosis,
and cardiovascular have been analyzed in the report.
The report is an outcome of an in depth research and prudent analysis
of the global IVD market that provides an effective description of
current market trends and their impact on industry structure. Areas,
such as North America, Europe, Japan, and other key countries are
covered in the report and reliable statistics have been provided with
respect to market size, players, and segments. Moreover, topics like
consumer behavior analysis, market drivers, recent developments, and
industry restraints are likely to provide clients a better industry
know-how and structure view.


For more information visit: Global In Vitro Diagnostic Market Analysis - Market Research Report

[smartinvest22]

GLGT 5's are back up, c'mon lets tear through these 5s and 6s, lets get back to 002-003 area by next week! Also I just got off the phone with the TA, the share structure remains intact! Float count 246 mil, looking for a bullish close here by EOD! GLGT

[smartinvest22]

Last time GLGT put out a merger PR it spiked up 120% in an instant! If they put out some sort of update today the market will have plenty of time to react to it throughout the ongoing week. And I have hard times understanding why this shouldn't be mu next 3-5 bagger play! Some ask slappage will send it off into stratosphere!!!

[smartinvest22]

GLGT a very nice pick, so undervalued here, looking for a breakout soon on ground shaking news! All triple zeros will be history soon! GLGT trades 3 times its 3 month avg volume!

[smartinvest22]

GLGT just got off the phone with the TA, the share count remains intact! Float count 246 mil, looking for a bullish close here by EOD! GLGT 5's are back up, c'mon lets tear through these 5s and 6s, lets get back to 002-003 area by next week!

[smartinvest22]

GLGT volume 23,770,564 so far and growing! Everyone's locked in on their position! GLGT big news to hit shortly!!! BUY-HOLD-REPEAT! GLGT

[smartinvest22]

GLGT - and last but certainly not least everything's thin until $0.02! This could fly another 100-300% easily! Put a strong pressure on ASK! GLGT - this last PR goes to show that they are in a full-time revenue stage and are able to put big moneys back into research&development!! Can't wait til the news hits!

[smartinvest22]

GLGT how I am reading those MMMG updates AB Biotech has some biz/developmental updates ready to push through the wires!!! GLGT

From MMG "Friday Tips":

GLGT
The company's new AB (Wuhan) Biotech subsidiary should soon be making
an exciting announcement about its involvement in a venture focused on
diagnosing, preventing and treating rabies.